Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions
This article was originally published in The Pink Sheet Daily
Executive Summary
Stakeholders discussed electronic cigarettes at an FDA public hearing on smoking cessation, reflecting big tobacco’s buy-in to the market. Firms appear to have a choice between remaining in tobacco’s regulatory space, or following the costly, potentially unclear route to an NDA.